These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The CD4-mediated immune response is critical in determining the outcome of infection using Theiler's viruses with VP1 capsid protein point mutations. Rodriguez M, Roos RP, McGavern D, Zoecklein L, Pavelko K, Sang H, Lin X. Virology; 2000 Sep 15; 275(1):9-19. PubMed ID: 11017783 [Abstract] [Full Text] [Related]
4. Conditional Silencing of H-2Db Class I Molecule Expression Modulates the Protective and Pathogenic Kinetics of Virus-Antigen-Specific CD8 T Cell Responses during Theiler's Virus Infection. Tritz ZP, Orozco RC, Malo CS, Ayasoufi K, Fain CE, Khadka RH, Goddery EN, Yokanovich LT, Settell ML, Hansen MJ, Jin F, Pavelko KD, Pease LR, Johnson AJ. J Immunol; 2020 Sep 01; 205(5):1228-1238. PubMed ID: 32737149 [Abstract] [Full Text] [Related]
5. Initial capsid-specific CD4(+) T cell responses protect against Theiler's murine encephalomyelitisvirus-induced demyelinating disease. Mohindru M, Kang B, Kim BS. Eur J Immunol; 2006 Aug 01; 36(8):2106-15. PubMed ID: 16761311 [Abstract] [Full Text] [Related]
20. Identification of capsid epitopes of Theiler's virus recognized by CNS-infiltrating CD4+ T cells from virus-infected C57BL/6 mice. Kang B, Kang HK, Kim BS. Virus Res; 2005 Mar 01; 108(1-2):57-61. PubMed ID: 15681055 [Abstract] [Full Text] [Related] Page: [Next] [New Search]